Latest News
BrightFocus Foundation, a Maryland-based nonprofit funding research worldwide on diseases of mind and sight, today announced that wealth management expert Patricia (Trisha) McGlothlin Stewart, CFP® has joined the organization’s Board of Directors.
Jan M. Stouffer, PhD, a polymer physicist and manager with over 30 years of experience in research and development, has joined the BrightFocus Foundation’s Board of Directors. The Foundation, a Maryland-based nonprofit, works to end Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation hosted an awards dinner on June 8 in Washington, DC to celebrate some of the world’s most promising science and public advocacy to end Alzheimer’s disease, macular degeneration, and glaucoma.
The summer edition of National Glaucoma Research Report outlines new research into the causes of glaucoma, drug screenings, and therapeutic strategies by generating retinal ganglion cells in a dish; a Q/A with Jeffrey Goldberg, MD, PhD on the frontlines of discovery; a spotlight on Meredith Gregory-Ksander, PhD, and her research that may stop glaucoma development and vision loss; and much more.
Noted vision researcher of the Netherlands receives the prestigious 2017 Helen Keller Prize for Vision Research.
Learn about new research that sheds light on sex-based differences in Alzheimer’s disease, how inflammation may be related to the development of Alzheimer’s, tips to engage someone who has Alzheimer’s in activities, and information about a citizen science project funded by BrightFocus Foundation that enables anyone to contribute to Alzheimer’s research by playing an online game, and more in the spring 2017 edition of Alzheimer’s Disease Research Review.
From Stacy Pagos Haller, President and CEO
The spring 2017 edition of Macular Degeneration Research News has information about a cancer drug that may lead to a new treatment for dry AMD, a story about how the implantable miniature telescope enhances sight in a patient with AMD, tips for how to make your home safer for people with low vision, and much more.
Learn about experimental drugs implanted in the eye that may enhance visual function, the genetic risks of developing glaucoma, how glaucoma can occur even when eye pressures is a normal range, and much more in the winter 2017 edition of the National Glaucoma Research Report.
BrightFocus Foundation today announced a record $13.3 million in new grants for promising science toward finding cures for Alzheimer’s disease, macular degeneration, and glaucoma.